2.4.1.65	(-)-epigallocatechin-3-gallate	time-dependent, irreversible	2518	
2.4.1.65	2'-fucosyllactose	-	2389	
2.4.1.65	2,3-Dihydroxybenzoic acid	-	3773	
2.4.1.65	2,4,6-Trinitrobenzenesulfonate	5 mM, activity is decreased to 82%; 5 mM, activity is decreased to 86%	3303	
2.4.1.65	2,4-dihydroxybenzoic acid	-	12297	
2.4.1.65	2,5-dihydroxybenzoic acid	-	6417	
2.4.1.65	3,4,5-Trihydroxybenzoic acid	gallic acid, time-dependent, irreversible	4477	
2.4.1.65	3,4,5-trimethoxybenzoic acid	-	23505	
2.4.1.65	3,4-dihydroxybenzoic acid	-	1781	
2.4.1.65	3,4-dimethoxybenzoic acid	-	9612	
2.4.1.65	3,5-dimethoxy 4-hydroxybenzoic acid	syringic acid	127324	
2.4.1.65	4-O-beta-D-galactopyranosyl-D-glucitol	competitive with respect to lactose	51752	
2.4.1.65	9-(5'-O-[(alpha,beta-L-fucopyranosyl)oxycarbonylaminosulfonyl]-beta-D-ribofuranosyl)-guanine	poor competitive inhibition	71043	
2.4.1.65	ADP	about 30% inhibition at 0.4 mM	13	
2.4.1.65	C-fucosyl analogon of GDP-fucose	-	57664	
2.4.1.65	carba-fucosyl analogon of GDP-fucose	-	57663	
2.4.1.65	Co2+	20 mM, 98% inhibition	23	
2.4.1.65	Cu2+	20 mM, complete inhibition	19	
2.4.1.65	dGDP	about 40% inhibition at 0.4 mM	1140	
2.4.1.65	dGDP	about 76% inhibition at 0.4 mM	1140	
2.4.1.65	diethylpyrocarbonate	0.5 mM, activity is decreased to 11%; 0.5 mM, activity is decreased to 13%	2270	
2.4.1.65	ellagic acid	-	1279	
2.4.1.65	ethylenediaminetetraacetic acid	-	10903	
2.4.1.65	Galbeta(1,3)GalNAc	-	33004	
2.4.1.65	Galbeta(1,4)(3-deoxy)GlcNAcbetaOallyl	IC50: 710 mM	51119	
2.4.1.65	Galbeta(1,4)deoxynojirimycin	IC50: 8 mM	51121	
2.4.1.65	GDP	0.05 mM	53	
2.4.1.65	GDP	competitive with respect to GDP-fucose	53	
2.4.1.65	GDP	about 78% inhibition at 0.4 mM	53	
2.4.1.65	GDP	about 80% inhibition at 0.4 mM	53	
2.4.1.65	GDP-6-amino-beta-L-fucose	about 45% inhibition at 1 mM	210450	
2.4.1.65	GDP-6-amino-beta-L-fucose	78% inhibition at 0.4 mM	210450	
2.4.1.65	GDP-Man	IC50: 2 mM	11128	
2.4.1.65	GMP	competitive with respect to GDP-fucose	162	
2.4.1.65	GTP	about 70% inhibition at 0.4 mM	37	
2.4.1.65	GTP	about 80% inhibition at 0.4 mM	37	
2.4.1.65	IDP	about 60% inhibition at 0.4 mM	444	
2.4.1.65	IDP	about 30% inhibition at 0.4 mM	444	
2.4.1.65	L-fucose	about 20% inhibition at 0.4 mM	717	
2.4.1.65	lacto-N-fucopentaitol I	-	51753	
2.4.1.65	methyl gallate	-	1402	
2.4.1.65	Mn2+	20 mM, 40% inhibition below pH 8.0	11	
2.4.1.65	additional information	the Silene alba alpha-4-FucT is insensitive to N-ethylmaleimide treatment (5 mM), in contrast to human FUT3	2	
2.4.1.65	additional information	not inhibited by GMP	2	
2.4.1.65	additional information	not inhibited by L-fucose, GMP and ADP	2	
2.4.1.65	N-bromosuccinimide	0.5 mM, activity is decreased to 8%; 0.5 mM, activity is decreased to 9%	208	
2.4.1.65	NEM	3 mM, 59°C	89	
2.4.1.65	NEM	-	89	
2.4.1.65	NEM	10 mM, 90% inhibition	89	
2.4.1.65	propyl gallate	-	1879	
2.4.1.65	unsaturated carba-fucosyl analogon of GDP-fucose	-	57665	
2.4.1.65	Zn2+	20 mM, complete inhibition	14	
2.4.1.65	Zn2+	-	14	
2.4.1.65	[1-(beta-D-fucopyranosyl)-1H-1,2,3-triazole-4-yl]methylguanosine diphosphate	about 70% inhibition at 0.4 mM	210455	
2.4.1.65	[1-(beta-D-fucopyranosyl)-1H-1,2,3-triazole-4-yl]methylguanosinediphosphate	about 74% inhibition at 0.4 mM	210452	
2.4.1.65	[1-(beta-D-galactopyranosyl)-1H-1,2,3-triazole-4-yl] methylguanosine diphosphate	about 76% inhibition at 0.4 mM	210453	
2.4.1.65	[1-(beta-D-galactopyranosyl)-1H-1,2,3-triazole-4-yl] methylguanosine diphosphate	about 73% inhibition at 0.4 mM	210453	
2.4.1.65	[1-(beta-D-lactosyl)-1H-1,2,3-triazole-4-yl]methylguanosine diphosphate	about 60% inhibition at 0.4 mM	210454	
2.4.1.65	[1-(beta-D-lactosyl)-1H-1,2,3-triazole-4-yl]methylguanosine diphosphate	about 45% inhibition at 0.4 mM	210454	
2.4.1.65	[1-(beta-L-fucopyranosyl)-1H-1,2,3-triazole-4-yl]methylguanosine diphosphate	about 58% inhibition at 0.4 mM	210451	
2.4.1.65	[1-(beta-L-fucopyranosyl)-1H-1,2,3-triazole-4-yl]methylguanosine diphosphate	about 60% inhibition at 0.4 mM	210451